1. Scottish One Health Antimicrobial Use and Resistance in 2017 Annual Report

2. Antibiotic use in humans

3. Total use of antibiotics in humans, DDD/1,000/day, 2013 to 2017

4. Total antibiotic use by prescriber type, DDD/1,000/day, in 2017

5. Antibiotic use in primary care, items/1,000/day, 2013 to 2017

6. Antibiotic prescribing in the community, items/1,000/day, 2013 and 2017

7. Antibiotic prescribing by nurses in primary care, items/1,000/day, 2013 to 2017

8. Antibiotic prescribing by dentists in primary care, items/1,000/day, 2013 to 2017

9. Antibiotic use within acute hospitals, DDDs/1,000 OBDs, 2013 to 2017

10. Antimicrobial resistance in humans

11. Incidence of Gram-negative bacteraemia due to the most commonly reported bacteria, 2013 to 2017

12. Proportions of E. coli bacteraemia isolates non-susceptible to commonly used antibiotics, 2013 to 2017

13. Proportions of K. pneumoniae bacteraemia isolates non-susceptible to commonly used antibiotics, 2013 to 2017

14. Proportions of K. oxytoca bacteraemia isolates non-susceptible to commonly used antibiotics, 2013 to 2017

15. Proportions of P. aeruginosa bacteraemia isolates non-susceptible to commonly used antibiotics, 2013 to 2017

16. Proportions of Acinetobacter spp
Proportions of Acinetobacter spp. bacteraemia isolates non-susceptible to commonly used antibiotics, 2013 to 2017

17. Incidence (per 100,000 population) of E
Incidence (per 100,000 population) of E. coli urinary isolates, 2013 to 2017

18. Proportions of E. coli urinary isolates non-susceptible to commonly used antibiotics, 2013 to 2017

19. Number of carbapenemase-producing organism (CPO) isolates by enzyme type, 2003 to 2017

20. Incidence of CPO isolates (per 100,000 population), 2013 to 2017

21. Incidence rates (per 100,000 population) of E. faecalis and E
Incidence rates (per 100,000 population) of E. faecalis and E. faecium bacteraemia, 2013 to 2017

22. Percentages of E. faecium bacteraemia isolates non-susceptible to vancomycin, 2013 to 2017

23. Episodes of N. gonorrhoeae by gender, 2013 to 2017

24. Use of triazoles and echinocandins in acute hospitals, DDD/1,000/OBDs, 2013 to 2017

25. Incidence rates (per 100,000 population) of candidaemia by species, 2013 to 2017

26. Salmonella from human laboratory confirmed reports 1990 to 2017

27. Proportions of human Salmonella isolates non-susceptible to selected antibiotics, 2013 to 2017

28. Antimicrobial resistance in animals

29. Number of laboratory confirmed reports of Salmonella isolates from animals, 2013 to 2017
In 2017, 72.1% of Salmonella isolates were fully sensitive to all antibiotics against which they were tested

30. Proportions of S. aureus companion animal isolates non-susceptible to commonly used antibiotics, 2013 to 2017

31. Proportions of S. pseudintermedius companion animal isolates non-susceptible to commonly used antibiotics, 2013 to 2017

32. Non-susceptibility of E
Non-susceptibility of E. coli isolates among bovine, ovine, porcine and poultry animals in 2017

33. The elements of Public Health Microbiology

34. Public Health Microbiology Functions

35. Steps involved in generating an AMR alert